GlassScriptPhysician profile
Jennifer Mears
NPI 1861471666
$485.95
in general payments reported to CMS, 2019-2025
9 companies · $46.58 in 2025
The $46.58 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $134 · 2023: $238 · 2024: $67.94 · 2025: $46.58.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $352.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $352.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mozarc Medical US LLC | $140.00 | 2023 | Argyle |
| Bard Peripheral Vascular, INC. | $120.02 | 2022 | |
| Baxter Healthcare | $97.55 | 2023 | |
| Calliditas Therapeutics US INC. | $25.57 | 2025 | Tarpeyo |
| Medtronic, INC. | $25.57 | 2024 | Symplicity G3 |
| Otsuka America Pharmaceutical, INC. | $25.36 | 2024 | Jynarque |
| Travere Therapeutics, INC. | $21.01 | 2025 | |
| Fresenius USA Marketing, INC. | $17.01 | 2024 | Crit-Line, Optiflux |
| Aurinia Pharma U.S., INC. | $13.86 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Mears listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.